1. Cardon, P.V., Dommel, F.W. and Trumble, R.R. Injuries to research subjects — a survey of investigators. New Engl. J. Med., 1976, 295, 650–654
2. Zarafonetes, C.J.D. et al. Clinically significant adverse events in a Phase 1 testing program. Clin. Pharmacol. Ther., 1978, 24 (2), 127–132
3. Kinney, E.L., Trautman, J., Gold, J.A., Vesell, E.S. and Zelis, R. Underrepresentation of women in new drug trials: ramification and remedies. Ann. Intern. Med., 1981, 915 (5), 560–563
4. General Considerations for the Clinical Evaluation of Drugs. Health, Education and Welfare (F.D.A), 77–3040, Sept. 1977, p.10
5. Hollister, L.E. Prediction of therapeutic uses of psychotherapeutic drugs from experience with normal volunteers. Clin. Pharmacol. Ther., 1972, 13 (2), 803–808